Khawla Abusamra

ORCID: 0000-0002-2730-6822
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Peripheral Neuropathies and Disorders
  • Retinal and Optic Conditions
  • Myasthenia Gravis and Thymoma
  • Vasculitis and related conditions
  • Autoimmune Neurological Disorders and Treatments
  • Multiple Sclerosis Research Studies
  • Herpesvirus Infections and Treatments
  • Renal Diseases and Glomerulopathies
  • Parkinson's Disease and Spinal Disorders
  • Porphyrin Metabolism and Disorders
  • Pituitary Gland Disorders and Treatments
  • Cytomegalovirus and herpesvirus research
  • Facial Nerve Paralysis Treatment and Research
  • Occupational Therapy Practice and Research
  • Viral Infections and Vectors
  • Retinal Diseases and Treatments
  • Alcoholism and Thiamine Deficiency
  • CNS Lymphoma Diagnosis and Treatment
  • Vector-Borne Animal Diseases
  • Neuroblastoma Research and Treatments
  • Drug-Induced Adverse Reactions
  • Global Health Workforce Issues
  • Antifungal resistance and susceptibility
  • Axon Guidance and Neuronal Signaling

University of Kentucky
2020-2023

Neurology, Inc
2023

Ocular Immunology and Uveitis Foundation
2017

Massachusetts Eye Research and Surgery Institute
2016-2017

Michigan State University
2014-2015

To assess long-term effectiveness of rituximab therapy for refractory noninfectious uveitis affecting the posterior segment.Retrospective case series. Patients diagnosed with recalcitrant who were treated intravenous infusions between 2010 and 2015 included. underwent best-corrected visual acuity testing fluorescein angiography evidence disk or vascular staining at 6, 12, 18, 24 months. had least months follow-up.Eleven patients (21 eyes) Nine (81.8%) female. Mean follow-up was 29.3 ± 7.8...

10.1097/iae.0000000000001563 article EN Retina 2017-02-22

Neuromyelitis Optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system (CNS) where aquaporin-4 water channels are antigenic target disease. The involves regions CNS channel widely expressed including spinal cord, optic nerve, dorsal medulla, brainstem, and thalamus/hypothalamus. Management NMOSD includes acute as well long term treatment. Acute symptoms typically treated with intravenous corticosteroids and/or plasma exchange while long-term treatment...

10.3389/fopht.2023.1130971 article EN cc-by Frontiers in Ophthalmology 2023-05-16

Stiff Person Syndrome (SPS) is a rare neurological disorder of unclear etiology characterized by two set symptoms; skeletal muscle stiffness and rigidity primarily affecting the truncal musculature due to continuous co-contracture agonist antagonist muscles, superimposed episodic spasms axial rigidity, limb stiffness, difficulty walking, postural instability. SPS classified into classic SPS, paraneoplastic variants- that include segmental Jerky Progressive encephalomyelitis with myoclonus,...

10.1016/j.nerep.2022.100116 article EN cc-by-nc-nd Neuroimmunology Reports 2022-01-01

There has been lot of speculation around the possible side effects associated with COVID vaccination and incidence facial palsy is one them. Bilateral less likely to be idiopathic as compared unilateral nerve warrants further investigations find any secondary cause. 19 infection vaccinations for same are also included in unique list differentials. We report an interesting case bilateral rapidly sequential following administration that showed subsequent improvement. provide literature review...

10.1016/j.nerep.2022.100141 article EN cc-by-nc-nd Neuroimmunology Reports 2022-01-01

Since the introduction of COVID-19 vaccine, various adverse events have been reported including injection site pain, fatigue, headaches, and myocarditis. Cranial neuropathies optic neuritis, also rarely reported, however, significance these autoimmune manifestations after administration vaccine remain controversial. In this report we present a case myocarditis bilateral neuritis that occurred in young healthy male patient first dose mRNA-1273 (Moderna).

10.1016/j.nerep.2022.100139 article EN cc-by-nc-nd Neuroimmunology Reports 2022-01-01

OBJECTIVE: To calculate the conversion rate to generalized myasthenia gravis (GMG), time conversion, and correlations with use of immunosuppressant therapy in ocular (OMG) patients. BACKGROUND: The initial presentation is limited pure symptoms approximately 60% cases. The subsequent GMG has been estimated at 50% 80%, 90% within first 3 years.DESIGN/METHODS:We conducted a retrospective review patients OMG who presented Michigan State University between 1993 2012. Inclusion criteria were age 蠅...

10.1212/wnl.82.10_supplement.p2.280 article EN Neurology 2014-04-08

<h3>Objective:</h3> NA <h3>Background:</h3> Creutzfeldt Jakob disease (CJD) is a rare and fatal neurodegenerative disorder of unclear etiology. Presentation include myoclonic jerks, visual disturbances, pyramidal/extrapyramidal signs rapidly progressive cognitive decline. Visual symptoms are common manifestation CJD. Here we present case vision loss initially attributed to cataract with eventual diagnosis <h3>Design/Methods:</h3> Patient 75-year-old woman history osteoporosis, dyslipidemia,...

10.1212/wnl.0000000000202908 article EN Neurology 2023-04-25

Central and peripheral nervous system infection due to cytomegalovirus (CMV) is extremely rare in immunocompetent patients. Here, we present an unusual case of a young African-American woman who developed severe form CMV encephalomyelitis polyradiculitis with prolonged complicated hospital course. The patient was treated course antiviral medications showed some improvement her symptoms. This presentation adds the limited literature on diagnosis, treatment prognosis hosts.

10.17925/usn.2022.18.2.157 article EN touchREVIEWS in Neurology 2022-01-01
Coming Soon ...